Zurueck zur Suche

Reporte zur Charge U019286

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 3 NH 1 DC 1 MI 1

VAERS 2372538

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019286

gering
Staat
NH
Alter
72,0
Geschlecht
F
Eingang
18.07.2022
Impfdatum
01.07.2022
Beginn
01.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Gave MMRV instead of MMR to patient. No symptoms, signs or adverse effects. No treatments.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Unk
Vorgeschichte
Unk
Andere Medikamente
Unk
Allergien
NKA
Vorherige Impfungen
-

VAERS 2125719

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019286

gering
Staat
DC
Alter
1,0
Geschlecht
F
Eingang
19.02.2022
Impfdatum
22.12.2021
Beginn
22.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fluid intake reduced SARS-CoV-2 test negative

Symptomtext

patient drank less fluid, patient refused to drink; This spontaneous report was received from the physician and refers to a 12-month-old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant medications included Vitamin D. On 22-DEC-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot #U019286, expiration date: 15-DEC-2022, administered subcutaneously for prophylaxis (strength and site of administration was not provided). Albumin status for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) has been verified as recombinant human albumin (rHA) On the night of 22-DEC-2021, the patient's mother noted that the patient drank less fluid, and on 23-DEC-2021 the patient refused to drink (considered as fluid intake reduced). The patient was still eating during this time. The patient's mother called the physician's office on 28-DEC-2021 because the patient still refused to drink. The physician saw the patient in the office on 28-DEC-2021, gave her "PEDIALYTE" for oral rehydration, and sent the patient home. The physician said the patient was seen again in the office the morning of 29-DEC-2021, and she continued to refuse to drink. The physician tested the patient for Covid on 29-DEC-2021, and the result was negative. The physician explained the patient started to drink more throughout the day on 29-DEC-2021. The physician reported the patient was fine and back to regular fluid intake on 30-DEC-2021. On that day, the patient recovered from the event fluid intake reduced. No additional information was provided. The causal relationship between the event of fluid intake reduced and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was not reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fluid intake reduced
Hospital-Tage
-
Labordaten
Test Date: 20211229; Test Name: Covid test; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
VITAMIN D NOS
Allergien
-
Vorherige Impfungen
-

VAERS 2053657

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019286

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
21.01.2022
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Vaccine administered after temparature excursion; No additional AEs; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, drug reactions or allergies and concomitant therapies were not provided. On 21-DEC-2021 the patient was vaccinated with measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) subcutaneous, 0.5 milliliter(ml), after temperature excursion (product storage error) (lot number U019286, expiration date 15-DEC-2022 ; vaccination scheme, and anatomical site of vaccination were not reported) for prophylaxis. The vaccine underwent a temperature excursion of 6.8 Fahrenheit (F) for 8 hours 5 minutes. There was no previous temperature excursion. No additional adverse events (no adverse event) or product quality complaints were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2050083

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019286

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
20.01.2022
Impfdatum
19.12.2021
Beginn
19.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AEs; Vaccine administered after temperature excursion; This spontaneous report was received from a nurse and referred to a patient of unspecified age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies, and concomitant therapies were not reported. On 19-DEC-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), 0.5 milliliter, lot number U019286, expiration date: 15-DEC-2022, administered subcutaneously as prophylaxis (strength and frequency were not provided). It was reported that the vaccine had experienced a temperature excursion (product storage error), for 8 hours and 5 minutes at 6.8 degrees Fahrenheit, no previous temperature excursions were reported. No additional events were reported. At the time of reporting, the outcome of the event was not known.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2030886

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019286

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
13.01.2022
Impfdatum
14.12.2021
Beginn
14.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; Improperly stored dose of PROQUAD administered; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 14-DEC-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # U019286, expiration date 15-DEC-2022 (therapy type rHA), 0.5 milliliter, subcutaneously, for prophylaxis. The vaccine was stored at a temperature of 6.8 fahrenheit degrees during 8 hours and 5 minutes. There were no previous temperature excursions. No adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1989385

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U019286

gering
Staat
MI
Alter
1,1
Geschlecht
F
Eingang
29.12.2021
Impfdatum
29.12.2021
Beginn
29.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Patient was given MMRV instead of regular MMR, n addition to Varicella vaccine. Resulting in a mega dose of Varicella.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Atopic dermatitis
Vorgeschichte
Atopic dermatitis
Andere Medikamente
D-Vi-Sol 10 mcg/ml 1 ml once a day Hydrocortisone topical cream 1% prn Hydrocortisone 2.5% topical cream 2 times daily
Allergien
No none allergies
Vorherige Impfungen
-